ev3 Inc. Market Share Analysis

GlobalData, September 2011, Pages: 137

ev3 Inc. Market Share Analysis

Summary

GlobalData’s new report, “ev3 Inc. Market Share Analysis” provides in-depth information on ev3 Inc.’s market position in the different medical equipment markets it operates in. The report provides ev3 Inc. market share information in two key market categories – Interventional Neurology and Peripheral Vascular Devices. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Global company shares (in Revenues) information for the key markets ev3 Inc. operates in – Interventional Neurology and Peripheral Vascular Devices.
- ev3 Inc.’s company shares (in Revenues) information for all the key countries the company has presence in – Brazil, United Kingdom, Spain, Italy, Germany, France, Japan, India, China, Australia, Canada and United States.
- All the key data-points are for 2010 and cover all the key regions – South and Central America, Europe, Asia-Pacific, Middle East and Africa and North America.
- Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company’s value proposition and the business climate it operates in..
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries, if any

Reasons to buy

- Develop sales and marketing strategies by identifying who-stands-where in the markets, ev3 Inc. operates in.
- Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to ev3 Inc.’s market positions.

1
1

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of Markets/Categories Covered
3.1 Interventional Neurology
3.2 Peripheral Vascular Devices
4 Company Snapshot
4.1 Key Information
4.2 Company Overview
4.3 SWOT Snapshot
5 Business Description
5.1 Business Overview
5.2 Neurovascular Segment
5.2.1 Overview
5.2.2 Financials
5.2.3 Market View
5.2.4 Key Strategies
5.3 Peripheral Vascular Segment
5.3.1 Overview
5.3.2 Financials
5.3.3 Market View
5.3.4 Key Strategies
5.4 Major Products and Services
5.4.1 Overview
6 History
7 SWOT Analysis
7.1 Overview
7.2 ev3 Inc. Strengths
7.2.1 Efficient Use of Resources
7.2.2 Expanding Operating Margin
7.2.3 Diversified Endovascular Product Portfolio
7.2.4 Expanding Market Share in the Sector
7.2.5 Sturdy Research Activities
7.3 ev3 Inc. Weaknesses
7.3.1 Decreased Demand for Plaque Excision Products
7.3.2 Product Recalls
7.4 ev3 Inc. Opportunities
7.4.1 Growing Peripheral Vascular Device Market
7.4.2 Growing Aged Population
7.4.3 Market Growth in Emerging Economies
7.4.4 Strategic Acquisitions
7.4.5 Robust Pipeline Products
7.5 ev3 Inc. Threats
7.5.1 Stringent Government Regulations
7.5.2 Rapid Technological Changes
7.5.3 Competitive Landscape
7.5.4 Industry Consolidation Challenges
7.5.5 Cost Containment Pressures
8 Competitors
9 Competitive Landscape
9.1 Peripheral Vascular Devices, Global, Market Share (%), 2010
9.2 Interventional Neurology, Global, Market Share (%), 2010
10 ev3 Inc. Medical Equipment Market Share Analysis
10.1 ev3 Inc., Global, Market Share (2010)
10.2 ev3 Inc., Asia-Pacific, Market Share (2010)
10.2.1 ev3 Inc., Australia, Market Share (2010)
10.2.2 ev3 Inc., China, Market Share (2010)
10.2.3 ev3 Inc., India, Market Share (2010)
10.2.4 ev3 Inc., Japan, Market Share (2010)
10.2.5 ev3 Inc., Other Asia-Pacific, Market Share (2010)
10.3 ev3 Inc., Europe, Market Share (2010)
10.3.1 ev3 Inc., France, Market Share (2010)
10.3.2 ev3 Inc., Germany, Market Share (2010)
10.3.3 ev3 Inc., Italy, Market Share (2010)
10.3.4 ev3 Inc., Spain, Market Share (2010)
10.3.5 ev3 Inc., United Kingdom, Market Share (2010)
10.3.6 ev3 Inc., Other Europe, Market Share (2010)
10.4 ev3 Inc., Middle East and Africa, Market Share (2010)
10.5 ev3 Inc., North America, Market Share (2010)
10.5.1 ev3 Inc., Canada, Market Share (2010)
10.5.2 ev3 Inc., United States, Market Share (2010)
10.6 ev3 Inc., South and Central America, Market Share (2010)
10.6.1 ev3 Inc., Brazil, Market Share (2010)
10.6.2 ev3 Inc., Other South and Central America, Market Share (2010)
11 Key Employees
12 Key Employee Biographies
13 Locations And Subsidiaries
13.1 Head Office
13.2 Other Locations & Subsidiaries
14 Financial Deals Landscape
14.1 ev3 Inc., Deals Volume Summary, 2006 to YTD 2011
15 ev3 Inc. Detailed Deal Summary
15.1 Venture Financing
15.1.1 Chestnut Medical Technologies Secures $7.8 Million In Venture Financing
15.1.2 Chestnut Medical Technologies Secures $0.83 Million In Series B Financing
15.1.3 Alsius Secures $10 Million In Series E Financing
15.2 Partnerships
15.2.1 ev3 Terminates Agreement With Bacchus Vascular
15.2.2 ev3 Enters Into Distribution Agreement With Lepu Medical
15.2.3 Volcano Signs An Agreement With ev3
15.2.4 ev3 And Foxhollow Enter Into Distribution Agreement
15.2.5 ev3 Enters Into An Agreement With Invatec
15.3 Equity Offering
15.3.1 ev3 Completes Public Offering Of $47.5 Million
15.3.2 ev3 Completes Initial Public Offering Of $164.71 Million
15.3.3 Micro Therapeutics Completes Private Placement Of 7% Exchangeable Notes For $21 Million
15.4 Asset Transactions
15.4.1 Atritech Completes Acquisition Of Intellectual Property From ev3 Endovascular
15.4.2 Edwards Acquires Percutaneous Heart Valve Technology From ev3
15.5 Acquisition
15.5.1 Covidien Completes Acquisition Of ev3 For $2.6 Billion
15.5.2 ev3 Completes Acquisition Of Chestnut Medical Technologies
15.5.3 ev3 Acquires Foxhollow Technologies
15.5.4 ev3 Acquires Micro Therapeutics
16 Recent Developments
16.1 Strategy And Business Planning
16.1.1 Jun 11, 2010: Ev3 To Expand Peripheral Vascular Manufacturing Facility In Minnesota
16.2 Financial Announcements
16.2.1 Apr 29, 2010: ev3 Reports Net Income Of $9.8 Million In Q1 2010
16.2.2 Feb 18, 2010: ev3 Reports Net Income Of $41.9 Million In 2009
16.2.3 Oct 27, 2009: ev3 Reports Net Income Of $6.7 Million In Q3 2009
16.2.4 Jul 28, 2009: ev3 Posts Net Income Of $24 Million In Q2 2009
16.2.5 Apr 28, 2009: ev3 Posts Net Loss Of $1.8 Million In Q1 2009
16.2.6 Feb 24, 2009: ev3 Reports 2008 Results
16.2.7 Oct 31, 2008: ev3 Reports 3Q 2008 Results
16.2.8 Jul 28, 2008: ev3 Reports 2Q 2008 Results
16.2.9 May 02, 2008: ev3 Reports Q1 2008 Results
16.2.10 Apr 18, 2008: ev3 To Declare Q1 2008 Results
16.2.11 Feb 22, 2008: ev3 Reports Q4 2007 Results
16.2.12 Feb 08, 2008: ev3 To Declare Q4 And 2007 Results
16.2.13 Jan 07, 2008: ev3 Reports Preliminary Q4 2007 Results and Revised 2008 Guidance
16.2.14 Oct 31, 2007: ev3 Reports Q3 2007 Results
16.2.15 Jul 22, 2007: ev3 Reports Q2 2007 Results
16.2.16 Apr 27, 2007: ev3 Reports Q1 2007 Results
16.2.17 Feb 20, 2007: ev3 Reports Year-End 2006 Results
16.2.18 Oct 20, 2006: ev3 Reports Q3 2006 Results
16.2.19 Jul 28, 2006: ev3 Reports Q2 2006 Results
16.3 Corporate Communications
16.3.1 Dec 15, 2009: Ev3 Promotes Pascal E.R. Girin To EVP, COO And David Mowry To SVP, President
16.3.2 Jan 09, 2009: ev3 Announces Management Changes
16.3.3 Dec 03, 2008: ev3 Appoints New Board Member
16.3.4 Aug 04, 2008: ev3 Appoints New Board Member
16.3.5 Jul 21, 2008: ev3 Announces Management Changes
16.3.6 Apr 07, 2008: ev3 Announces Management Changes
16.3.7 Feb 08, 2008: ev3 Chief Scientist And Board Member Resigns
16.3.8 Feb 27, 2007: ev3 Appoints New Director
16.4 Legal and Regulatory
16.4.1 Nov 02, 2010: CSI Settles Employee Lawsuit With ev3
16.4.2 Jul 06, 2010: ev3 Agrees To Settle Stockholder Litigation
16.4.3 Jun 01, 2010: Finkelstein Thompson LLP Announces Investigation Of ev3
16.5 Product News
16.5.1 Apr 11, 2011: Covidien Completes Patient Enrollment In Post-Market Study Of SilverHawk Atherectomy System
16.5.2 Dec 23, 2010: ev3 Initiates Voluntary Recall Of Specific Lots Of NanoCross 0.014" OTW PTA Dilatation Catheter
16.5.3 Jun 21, 2010: ev3 Announces Acceptance Of PMA Application Of Pipeline Embolization Device By FDA
16.5.4 May 18, 2010: ev3 Files PMA Application For Its Pipeline Embolization Device
16.5.5 May 10, 2010: ev3 Endovascular To Complete SWIFT Study For Solitaire FR Revascularization Device In Second Half Of 2011
16.5.6 Apr 26, 2010: ev3 Announces Completion Of Patient Enrollment In DURABILITY II Study For EverFlex Self-Expanding Stent System
16.5.7 Jan 05, 2010: ev3 Announces Trailblazer Support Catheter Recall
16.5.8 ec 09, 2008: ev3 Inc Receives FDA Clearance To Market EverCross Peripheral Angioplasty Balloons
16.5.9 Dec 18, 2007: ev3 Introduces New Enhanced Offering For The Treatment Of Peripheral Artery Disease
16.5.10 Dec 18, 2007: ev3 Introduces New Enhanced Offerings For The Treatment Of Peripheral Artery Disease
16.5.11 Jun 04, 2007: ev3 Receives Conditional IDE Approval To Study Use Of Protégé EverFlex Self-Expanding Stent System In The Treatment Of Peripheral Artery Disease
16.5.12 Apr 02, 2007: FoxHollow Filled 510(k) For The NightHawk System
17 Appendix
17.1 Research Methodology
17.2 Secondary Research
17.3 Primary Research
17.4 Models
17.5 Forecasts
17.6 Expert Panels
17.7 Consulting
17.8 Currency Conversion
17.9 Contact Us
17.10 Disclaimer

1.1 List of Tables
Table 1: ev3 Inc., Key Facts, 2010
Table 2: ev3 Inc., SWOT Analysis, 2010
Table 3: Peripheral Vascular Devices, Global, Company Share by Revenue ($m), 2010
Table 4: Interventional Neurology, Global, Company Share by Revenue ($m), 2010
Table 5: ev3 Inc., Medical Equipment, Global, Revenue ($m) and Market Share (%), 2010
Table 6: ev3 Inc., Medical Equipment, Asia-Pacific, Revenue ($m) and Market Share (%), 2010
Table 7: ev3 Inc., Medical Equipment, Australia, Revenue ($m) and Market Share (%), 2010
Table 8: ev3 Inc., Medical Equipment, China, Revenue ($m) and Market Share (%), 2010
Table 9: ev3 Inc., Medical Equipment, India, Revenue ($m) and Market Share (%), 2010
Table 10: ev3 Inc., Medical Equipment, Japan, Revenue ($m) and Market Share (%), 2010
Table 11: ev3 Inc., Medical Equipment, Other Asia-Pacific, Revenue ($m) and Market Share (%), 2010
Table 12: ev3 Inc., Medical Equipment, Europe, Revenue ($m) and Market Share (%), 2010
Table 13: ev3 Inc., Medical Equipment, France, Revenue ($m) and Market Share (%), 2010
Table 14: ev3 Inc., Medical Equipment, Germany, Revenue ($m) and Market Share (%), 2010
Table 15: ev3 Inc., Medical Equipment, Italy, Revenue ($m) and Market Share (%), 2010
Table 16: ev3 Inc., Medical Equipment, Spain, Revenue ($m) and Market Share (%), 2010
Table 17: ev3 Inc., Medical Equipment, United Kingdom, Revenue ($m) and Market Share (%), 2010
Table 18: ev3 Inc., Medical Equipment, Other Europe, Revenue ($m) and Market Share (%), 2010
Table 19: ev3 Inc., Medical Equipment, Middle East and Africa, Revenue ($m) and Market Share (%), 2010
Table 20: ev3 Inc., Medical Equipment, North America, Revenue ($m) and Market Share (%), 2010
Table 21: ev3 Inc., Medical Equipment, Canada, Revenue ($m) and Market Share (%), 2010
Table 22: ev3 Inc., Medical Equipment, United States, Revenue ($m) and Market Share (%), 2010
Table 23: ev3 Inc., Medical Equipment, South and Central America, Revenue ($m) and Market Share (%), 2010
Table 24: ev3 Inc., Medical Equipment, Brazil, Revenue ($m) and Market Share (%), 2010
Table 25: ev3 Inc., Medical Equipment, Other South and Central America, Revenue ($m) and Market Share (%), 2010
Table 26: ev3 Inc., Key Employees
Table 27: ev3 Inc., Other Locations
Table 28: ev3 Inc., Subsidiaries
Table 29: ev3 Inc., Deals Volume Summary, 2006 to YTD 2011
Table 30: ev3 Inc., Deals Summary, 2006 to YTD 2011
Table 31: Chestnut Medical Technologies Secures $7.8 Million In Venture Financing
Table 32: Chestnut Medical Technologies Secures $0.83 Million In Series B Financing
Table 33: Alsius Secures $10 Million In Series E Financing
Table 34: ev3 Terminates Agreement With Bacchus Vascular
Table 35: ev3 Enters Into Distribution Agreement With Lepu Medical
Table 36: Volcano Signs An Agreement With ev3
Table 37: ev3 And Foxhollow Enter Into Distribution Agreement
Table 38: ev3 Enters Into An Agreement With Invatec
Table 39: ev3 Completes Public Offering Of $47.5 Million
Table 40: ev3 Completes Initial Public Offering Of $164.71 Million
Table 41: Micro Therapeutics Completes Private Placement Of 7% Exchangeable Notes For $21 Million
Table 42: Atritech Completes Acquisition Of Intellectual Property From ev3 Endovascular
Table 43: Edwards Acquires Percutaneous Heart Valve Technology From ev3
Table 44: Covidien Completes Acquisition Of ev3 For $2.6 Billion
Table 45: ev3 Completes Acquisition Of Chestnut Medical Technologies
Table 46: ev3 Acquires Foxhollow Technologies
Table 47: ev3 Acquires Micro Therapeutics
Table 48: USD to Local Currency, Average Exchange Rate, 2010

1.2 List of Figures
Figure 1: Peripheral Vascular Devices, Global, Market Share (%), 2010
Figure 2: Interventional Neurology, Global, Market Share (%), 2010
Figure 3: ev3 Inc., Medical Equipment, Global, Revenue Share (%), 2010
Figure 4: ev3 Inc., Medical Equipment, Global, Market Share (%), 2010
Figure 5: ev3 Inc., Medical Equipment, Asia-Pacific, Revenue Share (%), 2010
Figure 6: ev3 Inc., Medical Equipment, Asia-Pacific, Market Share (%), 2010
Figure 7: ev3 Inc., Medical Equipment, Australia, Revenue Share (%), 2010
Figure 8: ev3 Inc., Medical Equipment, Australia, Market Share (%), 2010
Figure 9: ev3 Inc., Medical Equipment, China, Revenue Share (%), 2010
Figure 10: ev3 Inc., Medical Equipment, China, Market Share (%), 2010
Figure 11: ev3 Inc., Medical Equipment, India, Revenue Share (%), 2010
Figure 12: ev3 Inc., Medical Equipment, India, Market Share (%), 2010
Figure 13: ev3 Inc., Medical Equipment, Japan, Revenue Share (%), 2010
Figure 14: ev3 Inc., Medical Equipment, Japan, Market Share (%), 2010
Figure 15: ev3 Inc., Medical Equipment, Other Asia-Pacific, Revenue Share (%), 2010
Figure 16: ev3 Inc., Medical Equipment, Other Asia-Pacific, Market Share (%), 2010
Figure 17: ev3 Inc., Medical Equipment, Europe, Revenue Share (%), 2010
Figure 18: ev3 Inc., Medical Equipment, Europe, Market Share (%), 2010
Figure 19: ev3 Inc., Medical Equipment, France, Revenue Share (%), 2010
Figure 20: ev3 Inc., Medical Equipment, France, Market Share (%), 2010
Figure 21: ev3 Inc., Medical Equipment, Germany, Revenue Share (%), 2010
Figure 22: ev3 Inc., Medical Equipment, Germany, Market Share (%), 2010
Figure 23: ev3 Inc., Medical Equipment, Italy, Revenue Share (%), 2010
Figure 24: ev3 Inc., Medical Equipment, Italy, Market Share (%), 2010
Figure 25: ev3 Inc., Medical Equipment, Spain, Revenue Share (%), 2010
Figure 26: ev3 Inc., Medical Equipment, Spain, Market Share (%), 2010
Figure 27: ev3 Inc., Medical Equipment, United Kingdom, Revenue Share (%), 2010
Figure 28: ev3 Inc., Medical Equipment, United Kingdom, Market Share (%), 2010
Figure 29: ev3 Inc., Medical Equipment, Other Europe, Revenue Share (%), 2010
Figure 30: ev3 Inc., Medical Equipment, Other Europe, Market Share (%), 2010
Figure 31: ev3 Inc., Medical Equipment, North America, Revenue Share (%), 2010
Figure 32: ev3 Inc., Medical Equipment, North America, Market Share (%), 2010
Figure 33: ev3 Inc., Medical Equipment, Canada, Revenue Share (%), 2010
Figure 34: ev3 Inc., Medical Equipment, Canada, Market Share (%), 2010
Figure 35: ev3 Inc., Medical Equipment, United States, Revenue Share (%), 2010
Figure 36: ev3 Inc., Medical Equipment, United States, Market Share (%), 2010
Figure 37: ev3 Inc., Medical Equipment, South and Central America, Revenue Share (%), 2010
Figure 38: ev3 Inc., Medical Equipment, South and Central America, Market Share (%), 2010
Figure 39: ev3 Inc., Medical Equipment, Brazil, Revenue Share (%), 2010
Figure 40: ev3 Inc., Medical Equipment, Brazil, Market Share (%), 2010
Figure 41: ev3 Inc., Medical Equipment, Other South and Central America, Revenue Share (%), 2010
Figure 42: ev3 Inc., Medical Equipment, Other South and Central America, Market Share (%), 2010
Figure 43: ev3 Inc., Deals Volume Summary, 2006 to YTD 2011

Abbott Laboratories
Accuray Incorporated
ASAHI INTECC CO., LTD.
B. Braun Melsungen AG
Biosense Webster, Inc.
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
C.R. Bard, Inc.
Cadwell Laboratories, Inc.
CareFusion Corporation
Cordis Corporation
Covidien plc
Cyberonics, Inc.
DePuy, Inc.
Edwards Lifesciences Corporation
Elekta AB
Goodman Co., Ltd.
Integra LifeSciences Holdings Corporation
MAQUET GmbH & Co. KG
Medtronic, Inc.
Micrus Endovascular Corporation
Mizuho Ikakogyo Co., Ltd.
Natus Medical Incorporated
Nihon Kohden Corporation
Philips Healthcare
Sorin Group
St. Jude Medical, Inc.
Terumo Corporation
Thoratec Corporation

Customers who bought this item also bought

• Top Five Global Electric Vehicle Companies: Performance, Strategies and Competitive Analysis
• Supplying Ford 2012
• Supplying Chrysler
• Ford Motor Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Global Automotive Head-up Display Market 2012-2016
• General Motors Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• American Tire Distributors Holdings, Inc. - Strategic SWOT Analysis Review
• Global Friction Products Market 2012-2016
• Supplying the Volkswagen Group
• American Axle & Manufacturing Holdings, Inc. (AXL) - Financial and Strategic SWOT Analysis Review